Roger C. Lucas, Director at ChemoCentryx, Inc. (CCXI), sold 4,000 shares at $5.07 ($20K) on 2016-09-01, disclosed to the SEC on 2016-09-02.
Scheduled sale ($20k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TECH | SELL | 2017-08-14 | $11K | — | Filing → |
| CCXI | SELL | 2017-08-03 | $23K | — | Filing → |
| TECH | SELL | 2017-07-12 | $12K | — | Filing → |